GenPhar, Inc | GenPhar Appoints <strong>Dr. Ken Wang as Manager of Process Development</strong>

News

2009-05-18

GenPhar Appoints Dr. Ken Wang as Manager of Process Development

Mount Pleasant, South Carolina, United States of America, May 18, 2009

GenPhar, Inc. announced the appointment of Dr. Ken (Zhongde) Wang to the position of Manager for Production. Dr. Wang will lead the effort in operating GenPhar’s new 16,000 sq ft cGMP vaccine manufacturing facility.

Prior to joining GenPhar, Dr. Wang was a key member of the vaccine development team at the Division of Translational Vaccine Research, Department of Virology at Beckman Research Institute, City of Hope Medical Center. Dr. Wang has extensive experience in managing vaccine production validation for clinical trials.

Dr. Wang has 20 years experience in the areas of molecular biology, virology, biochemistry, microbiology and immunology, with eight years of management experience in late-stage product development and production process development. Dr. Wang was also responsible for establishing quality control and quality assessment criteria under FDA guidelines. Dr. has published over 30 peer-reviewed articles describing his scientific achievements. “Ken’s extensive experience and deep knowledge in manufacturing quality control process will be essential for establishment of GenPhar’s vaccine manufacturing capability,” as commented by Dr. Jan Woraratanadharm, the Manager for Medical and Scientific Affairs at GenPhar, Inc.

About GenPhar, Inc.

GenPhar, Inc. is a biopharmaceutical company dedicated to becoming a leader in developing and producing prophylactic and therapeutic vaccines to protect against the world’s most dangerous diseases. To reach its goals, GenPhar will leverage the advantage of its proven safe and effective ProVax and TheraVax vaccine platforms -- unique technology capable of producing multiple vaccine products. GenPhar's products are divided into two main areas: vaccines for biodefense and vaccines for chronic infectious diseases (including HIV, hepatitis B and hepatitis C). These products will have a large scale socio-economic impact and transformative effect on current research and treatments. GenPhar was founded in 1999 and is headquartered in Mount Pleasant, South Carolina.

To learn more about GenPhar and its vaccine programs, please contact us.